We are live on
!
Find out more
OM
Opaleye Management Portfolio holdings
AUM
$758M
1-Year Est. Return
124.8%
This Fund
S&P 500
This Quarter
Est. Return
+15.57%
1 Year Est. Return
+124.8%
3 Year Est. Return
+486.05%
5 Year Est. Return
+742.19%
10 Year Est. Return
+62,231.09%
AUM
$758M
AUM Growth
+$493K
(+0.07%)
Cap. Flow
-$40.4M
Cap. Flow
% of AUM
-5.33%
Top 10 Holdings %
Top 10 Hldgs %
61.52%
Holding
62
New
8
Increased
18
Reduced
13
Closed
9
Top Buys
| 1 |
UroGen Pharma
URGN
|
+$23.3M |
| 2 |
Disc Medicine
IRON
|
+$15.3M |
| 3 |
Perspective Therapeutics
CATX
|
+$14.7M |
| 4 |
MeiraGTx Holdings
MGTX
|
+$13.2M |
| 5 |
Q32 Bio
QTTB
|
+$4.95M |
Top Sells
| 1 |
Harrow
HROW
|
+$47.2M |
| 2 |
Rhythm Pharmaceuticals
RYTM
|
+$20.1M |
| 3 |
CG Oncology
CGON
|
+$17.9M |
| 4 |
Alkermes
ALKS
|
+$13.7M |
| 5 |
Ocular Therapeutix
OCUL
|
+$9.48M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Harrow
HROW
$1.55B
| $99.9M | 13.17% |
2,832,230
-1,072,770
| -27% | -$47.2M |
|
2
Liquidia Corp
LQDA
$6.57B
| $88.8M | 11.71% |
2,545,000
+110,000
| +5% | +$4.08M |
|
3
Eton Pharmaceutcials
ETON
$1.02B
| $70.6M | 9.31% |
2,860,000
| – | – |
|
4
Sol-Gel Technologies
SLGL
$241M
| $39.6M | 5.22% |
500,000
+46,261
| +10% | +$3.34M |
|
|
5
Rhythm Pharmaceuticals
RYTM
$7.5B
| $35.3M | 4.66% |
123,000
-207,000
| -63% | -$20.1M |
|
6
Apogee Therapeutics
APGE
$10.1B
| $32.8M | 4.33% |
390,000
+1,743
| +0.4% | +$127K |
|
|
7
Disc Medicine
IRON
$2.85B
| $26.9M | 3.55% |
421,000
+221,000
| +111% | +$15.3M |
|
|
8
UroGen Pharma
URGN
$1.91B
| $25.7M | 3.39% |
1,430,000
+1,161,577
| +433% | +$23.3M |
|
|
CBIO
9
Crescent Biopharma
CBIO
$428M
| $24.1M | 3.18% |
1,312,615
+134,315
| +11% | +$1.54M |
|
10
Stoke Therapeutics
STOK
$1.82B
| $22.8M | 3.01% |
700,000
+5,000
| +0.7% | +$164K |
|
|
11
Perspective Therapeutics
CATX
$338M
| $19.5M | 2.57% |
4,675,000
+3,490,500
| +295% | +$14.7M |
|
12
Rezolute
RZLT
$460M
| $19.2M | 2.53% |
6,300,000
+12,844
| +0.2% | +$38.5K |
|
|
13
MeiraGTx Holdings
MGTX
$1.15B
| $18.4M | 2.42% |
2,123,259
+1,732,415
| +443% | +$13.2M |
|
14
TG Therapeutics
TGTX
$8.44B
| $17.8M | 2.34% |
535,000
| – | – |
|
|
SNWV
15
SANUWAVE Health Inc
SNWV
$102M
| $17M | 2.24% |
981,267
| – | – |
|
16
Edgewise Therapeutics
EWTX
$4.23B
| $15.8M | 2.08% |
500,000
| – | – |
|
|
ACOG
17
Alpha Cognition
ACOG
$169M
| $14.1M | 1.85% |
2,561,950
+491,166
| +24% | +$2.79M |
|
18
Annexon
ANNX
$899M
| $12.9M | 1.7% |
2,331,761
-268,239
| -10% | -$1.51M |
|
|
ALMS
19
Alumis Inc
ALMS
$3.47B
| $12.1M | 1.6% |
550,000
+15,000
| +3% | +$375K |
|
20
Codexis
CDXS
$199M
| $11.1M | 1.46% |
6,785,000
-4,738
| -0.1% | -$6.75K |
|
21
Protagonist Therapeutics
PTGX
$8.38B
| $10.5M | 1.39% |
100,000
-5,000
| -5% | -$443K |
|
22
Revolution Medicines
RVMD
$39.3B
| $9.72M | 1.28% |
100,000
| – | – |
|
23
Xoma
XOMA
$710M
| $9.41M | 1.24% |
300,000
+7,410
| +3% | +$198K |
|
|
24
Q32 Bio
QTTB
$386M
| $8.06M | 1.06% |
1,256,228
+1,042,865
| +489% | +$4.95M |
|
|
MBX
25
MBX Biosciences
MBX
$2.6B
| $7.76M | 1.02% |
260,000
| – | – |
|
Similar funds
WCFA
SIG
GWM
IAS
TVAMP
RFM
MWA
CFS